The mTOR kinase inhibitor everolimus synergistically enhances the anti‐tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS‐123 on Mantle cell lymphoma
Jiao Li; Xiaogan Wang; Yan Xie; Zhitao Ying; Weiping Liu; Lingyan Ping; Chen Zhang; Zhengying Pan; Ning Ding; Yuqin Song; Jun Zhu
Author Information: Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of lymphoma
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.